Home | Founder | What's New | In The News | Consulting | |||||||
H1N1 Consulting Paradigm Shift Intervention Monitoring |
Audio:Nov18
Dec16
Jan4
Jan20
twitter
Commentary
The presence in wild birds led to the prediction that clade 2.3.2 would migrate to Mongolia and Russia, which was confirmed in 2009 isolates, which led to the prediction that clade 2.3.2 would migrate to Europe, the Middle East, and Africa, as predicted and confirmed for the Qinghai strain (clade 2.2). A 2011 H5N1 sequence, A/whooper swan/Hokkaido/4/2011, has been released by Hokkaido University at Genbank. The sequence is clade 2.3.2, as expected, but it has the receptor binding domain change S227R. In 2005, the acquisition of S227N by clade 2.2 was predicted, based recombination between donor sequences in H9N2 in the Middle East and Qinghai H5N1. The ability of H5N1 with S227N to bind to human receptors led to the prediction of human cases in the Middle East, which was confirmed in the sequence from the index cases in Turkey in 2006. S227N was in two of the four human sequences in Turkey and appeared in subsequent human H5N1 sequences in Egypt. Moreover, additional receptor binding domain changes, V223I and M230I were found in human sequences from the Gharbya cluster. The presence of V223I and M230I in clade 2.3.2 Fujian sequences raised concerns about human transmission. The detection of S227R in the recent H5N1 sequence from Japan increases those concerns. Media link Recombinomics
Presentations |
||||||||||
|
Webmaster:
webmaster@recombinomics.com
© 2011
Recombinomics. All
rights
reserved.